Santana-Bagur , Jorge L.

Santana-Bagur , Jorge L.

Faculty Member

Positions

Professor Medicine & Infectious Disease, Director & Principal Investigator ACTU / Medicine; Associate Editor Puerto Rico Health Science Journal , University of Puerto Rico - Arecibo

overview

Dr Santana has a 34-year trajectory in the Infectious Disease field, with ample experience in Clinical Research in HIV pathogenesis, antiretroviral therapy, comorbid conditions, prevention and over 23-year clinical research in Hepatitis C co-infection, as well as a shared passion with viral infections.

member of

selected publications

academic article
- A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. The Lancet Gastroenterology & Hepatology. 7:307-317. 2022
- Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy. The Journal of Infectious Diseases. 222:601-610. 2020
- Public Health Academic Alliance for COVID-19 Response: The Role of a National Medical Task Force in Puerto Rico. International Journal of Environmental Research and Public Health. 17:4839. 2020
- PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305). The Journal of Infectious Diseases. jiw525. 2016
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. New England Journal of Medicine. 373:705-713. 2015

research overview

Translational Antiretrovirals, Clinical Research and Co Morbid conditions HIV, HCV, ZIKA, RSV, COVID-19 ART and Long COVID (PASC)

full name

Jorge L. Santana-Bagur

primary email

jorge.santana3@upr.edu

webpage

https://md.rcm.upr.edu/actu5401/

phone

787-767-9195

Publications in VIVO

Co-author Network

Contact Info

jorge.santana3@upr.edu

787-767-9195

Websites

https://md.rcm.upr.edu/actu5401/